ENTRY RATE AND METABOLISM OF LEUKOTRIENE C-4 INTO VASCULAR COMPARTMENT IN HEALTHY-SUBJECTS

被引:40
作者
MACLOUF, J
ANTOINE, C
DECATERINA, R
SICARI, R
MURPHY, RC
PATRIGNANI, P
LOIZZO, S
PATRONO, C
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DENVER, CO 80206 USA
[2] CNR, INST CLIN PHYSIOL, I-56100 PISA, ITALY
[3] UNIV CATTOLICA SACRO CUORE, SCH MED, DEPT PHARMACOL, I-00168 ROME, ITALY
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1992年 / 263卷 / 01期
关键词
LEUKOTRIENE E4; 16-CARBOXY-LTE4; 14-CARBOXY-LTE3; URINARY EXCRETION;
D O I
10.1152/ajpheart.1992.263.1.H244
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We measured the excretion of a major urinary metabolite of leukotriene (LT) C4, i.e., LTE4, during the infusion of exogenous LTC4 to enable estimation of the rate of entry of endogenous LTC4 into the bloodstream. Four healthy volunteers received 2-h intravenous infusions of vehicle alone and LTC4 at 0.063, 0.32, 1.6, and 2.9 pmol.kg-1.min-1 in random order. Urinary LTE4 was measured before, during, and up to 24 h after the infusions. The fractional elimination of LTE4 was independent of the rate of LTC4 infusion and averaged 4.3 +/- 0.9%. Calculation of the mean rate of entry of LTC4 into the circulation was found to be 0.06 pmol.kg-1.min-1. In addition, we characterized further metabolism of [C-14]LTC4. The two major urinary metabolites were the omega-and beta-oxidation products (16-COOH-LTE4 and 14-COOH-LTE3), which accounted for 6-8% of the total infused amount of [C-14]LTC4. We conclude that 1) LTC4 is produced at a low rate under physiological circumstances and is rapidly converted in the vasculature to LTE4, 2) changes in the urinary excretion of the latter may reliably reflect short-term changes in the rate of secretion of LTC4, and 3) measurement of the omega- and beta-oxidation products may reflect chronic changes in cysteinyl leukotriene biosynthesis.
引用
收藏
页码:H244 / H249
页数:6
相关论文
共 25 条
[1]   DEVELOPMENT OF ENZYME IMMUNOASSAYS FOR LEUKOTRIENES USING ACETYLCHOLINESTERASE [J].
ANTOINE, C ;
LELLOUCHE, JP ;
MACLOUF, J ;
PRADELLES, P .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1075 (02) :162-168
[2]  
DENZLINGER C, 1986, J BIOL CHEM, V261, P5601
[3]  
Draper N.F., 1966, APPL REGRESSION ANAL, P44
[4]   ESTIMATED RATE OF PROSTACYCLIN SECRETION INTO THE CIRCULATION OF NORMAL MAN [J].
FITZGERALD, GA ;
BRASH, AR ;
FALARDEAU, P ;
OATES, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1272-1276
[5]   ANALYSIS OF PROSTACYCLIN AND THROMBOXANE BIOSYNTHESIS IN CARDIOVASCULAR-DISEASE [J].
FITZGERALD, GA ;
PEDERSEN, AK ;
PATRONO, C .
CIRCULATION, 1983, 67 (06) :1174-1177
[6]   ANALYSIS OF CYSTEINYL LEUKOTRIENES IN HUMAN-URINE - ENHANCED EXCRETION IN PATIENTS WITH LIVER-CIRRHOSIS AND HEPATORENAL-SYNDROME [J].
HUBER, M ;
KASTNER, S ;
SCHOLMERICH, J ;
GEROK, W ;
KEPPLER, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1989, 19 (01) :53-60
[7]   THE EFFECTS OF A 5-LIPOXYGENASE INHIBITOR ON ASTHMA INDUCED BY COLD, DRY AIR [J].
ISRAEL, E ;
DERMARKARIAN, R ;
ROSENBERG, M ;
SPERLING, R ;
TAYLOR, G ;
RUBIN, P ;
DRAZEN, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1740-1744
[8]  
KEPPLER D, 1989, ADV ENZYME REGUL, V28, P307
[9]   REDUCED ALLERGEN-INDUCED NASAL CONGESTION AND LEUKOTRIENE SYNTHESIS WITH AN ORALLY ACTIVE 5-LIPOXYGENASE INHIBITOR [J].
KNAPP, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1745-1748
[10]   THE BIOLOGICALLY-ACTIVE LEUKOTRIENES - BIOSYNTHESIS, METABOLISM, RECEPTORS, FUNCTIONS, AND PHARMACOLOGY [J].
LEWIS, RA ;
AUSTEN, KF .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (04) :889-897